Immunohistochemical characteristics of haemangiopericytic meningiomas: comparison with typical meningiomas, haemangioblastomas and haemangiopericytomas from extracranial sites.
The relationship between malignant vascular meningeal tumours and typical meningiomas remains controversial, despite the need for accurate diagnostic distinction between the two, and some forms of vascular meningioma may be more closely allied to haemangioblastomas or extracranial haemangiopericytomas than to true meningiomas. In order to try to clarify the diagnostic characteristics and origins of the entity known as haemangiopericytic meningioma, 10 histologically typical cases were stained by the immunoperoxidase technique with a panel of seven antibodies. The results were compared with those obtained from typical and angiomatous meningiomas, haemangioblastomas and haemangiopericytomas from extracranial sites. Both the haemangiopericytic meningiomas and the extracranial haemangiopericytomas showed a similar staining pattern, which differed from that of the typical and angiomatous meningiomas in the strikingly focal nature of the vimentin staining and the lack of reactivity with antibodies to epithelial elements. The haemangioblastomas were less consistent in their individual staining characteristics, but had a quite different overall pattern from all the other tumour types. It is, therefore, suggested that so-called haemangiopericytic meningiomas are in fact primary haemangiopericytomas of the meninges, antigenically distinct from true meningiomas and displaying a malignant potential appropriate to haemangiopericytomas arising in any other sites.
D000911:Antibodies, Monoclonal; D000941:Antigens / Q000032:analysis; D003893:Desmin / Q000032:analysis; D005169:Factor VIII / Q000032:analysis / Q000276:immunology; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis; D006393:Hemangiopericytoma / Q000032:analysis / Q000097:blood* / Q000145:classification; D006394:Hemangiosarcoma / Q000032:analysis / Q000098:blood supply* / Q000145:classification; D006801:Humans; D007150:Immunohistochemistry; D007633:Keratins / Q000032:analysis; D008577:Meningeal Neoplasms / Q000032:analysis / Q000098:blood supply* / Q000145:classification; D008579:Meningioma / Q000032:analysis / Q000098:blood supply* / Q000145:classification; D009418:S100 Proteins / Q000032:analysis; D014841:von Willebrand Factor
D000911:Antibodies, Monoclonal; D000941:Antigens; D003893:Desmin; D005904:Glial Fibrillary Acidic Protein; D009418:S100 Proteins; D014841:von Willebrand Factor; D007633:Keratins; D005169:Factor VIII